Our purpose was to the compare fetal heart reaction to external physical stimulation with the nonstress test (NST).
INTRODUCTION
Fetal well-being is commonly evaluated by cardiotocography or ultrasound. The biophysical profile grades five components: fetal tone, movement, breathing, amniotic fluid volume, and heart rate tracing. The last is formally evaluated by the nonstress test (NST). Fetal movement, either spontaneous or induced (as by acoustic stimulation), may be associated with an increase in the fetal heart rate. 1, 2 A prior prospective evaluation of ultrasound transducer stimulation of fetal movement found high predictive value of the positive for an observed acceleration of the fetal heart rate of Z15 beats per minute (BPM) and a reactive NST. 3 The fetal stimulation appeared safe, but only 159 studies were reported.
The purpose of this study was to gain further experience concerning an ultrasound transducer-induced fetal heart rate change (the startle) and the NST.
MATERIALS AND METHODS
The studied patients were referred by their attending obstetrician for a fetal biophysical profile and NST. Among the reported patients, the biophysical profile was evaluated within 2 hours of the NST. Customarily, less than 30 minutes separated the two. All ultrasound examinations were performed by a single observer (JMM), unaware of the NST result. Standard criteria were used for a reactive NST: two or more fetal heart rate accelerations of at least 15 BPM above the baseline, lasting 15 seconds or more, in a 20-minute period. 1 A nonreactive NST was defined as a 40-minute period without accelerations. Prior to performing a biophysical profile and while the fetus was not actively moving or breathing, the fetal heart rate was determined by M-mode. After the rate was confirmed, gentle movement of the transducer stimulated the fetus over the area of the fetal small parts. Three to six quick indentations were made over a period of 3 to 6 seconds. Each indentation depressed the maternal abdomen by 2 to 4 cm. The fetal heart rate was recorded 5 to 15 seconds later, again documented by M-mode measuring one to three fetal heart beats. The change in the fetal heart rate was compared to the NST. An increase of Z15 BPM was considered a positive response. All studies were performed between April 1999 and August 2002. The hospital institutional review board approved the study. Informed consent was obtained prior to patient participation in the study. Only the formal NST was used in compiling the reported biophysical profile. The change in the heart rate was neither reported nor used in patient management.
Data were compared using the nonparametric Fisher exact test or Wilcoxon rank sums as appropriate.
Based on our prior study, we assumed that 60% of patients with a reactive NST as opposed to 5% of patients with a nonreactive NST would exhibit a positive startle response. Assuming 10% of patients tested would have a nonreactive NST with a ¼ 0.05 and b ¼ 0.20 (power ¼ 0.80), 58 studies were needed.
RESULTS
Study material was drawn from 235 studies conducted on a data set of 194 patients that included four sets of twins. Gestational age ranged from 25 to 41 weeks (median ¼ 36). The gestational age of testing was not found to be different for the 19 nonreactive NSTs (25 to 39 weeks, median ¼ 35) than the 216 reactive NSTs (26 to 41 weeks, median ¼ 36). The most common primary indications were the following: diabetes 51, pre-eclampsia 42, fetal growth restriction 32, hypertension 30, decreased fetal movement 27, and maternal injury 16.
Patients with reactive NSTs had startle responses ranging from 2 to 46 BPM (median ¼ 17); those with nonreactive NSTs were significantly different, range À8 to 13 (median ¼ 5), p<0.001.
When reanalyzed as a dichotomous variable, a highly significant relationship between observed fetal heart rate change and the nonstress test was found (Table 1) , p<0.001. The predictive value of the positive (startle Z15 and reactive NST) was 100%. The negative predictive value was only 23.6%. A receiveroperating characteristic curve was constructed comparing the startle response with the NST. The area under the curve was 0.948±0.024, p<0.001.
In total, 34 patients had repeat studies (1 set of twins). Of these 37 NSTs, two were nonreactive, not significantly different from the 17 of 198 NSTs from fetuses evaluated only once.
Untoward events of the ultrasound-induced startle were absent. Neither abruption nor acute distress occurred. All patients delivered live born infants.
DISCUSSION
External manipulation has been employed to activate the resting fetus. 4 Several studies have found that stimulation of the fetus could be used to evaluate fetal well-being. Vibroacoustic stimulation has been shown to increase the fetal heart rate and shorten the time needed for fetal heart rate testing. 1 Results in this report confirmed our prior findings. Sensitivity and specificity were similar 69.9 vs 59.6% and 100 vs 100%. The data appeared reproducible as shown by similar areas under the receiver-operating characteristic curves, 0.948 vs. 0.972 for the two studies.
From this study, an observed increase in the fetal heart rate of 15 BPM or more above baseline was strongly associated with a reactive NST. Among tested patients, two-thirds of reactive NST studies would be unnecessary since an acceleration of Z15 BPM could have been substituted for a reactive NST. Clinical application would apply to screening situations when rapid, brief assessments, such as an AFI plus NST are being utilized. Documentation of the fetal heart rate acceleration by ultrasound and an adequate AFI could quickly screen a fetus, both freeing up providers for other activities and reducing cost to the patient.
Concerns about the limited nature of documenting the response exist. The maximal increase may not have been identified. Measurement over a brief time (one to three beats) also is limiting. Only a single response to fetal movement was obtained. The usefulness of repeating the startle is unknown.
In our prior report, 13 of 45 nonreactive NSTs were associated with change of the fetal heart rate of 0 BPM or less. Only four of 19 patients in this study had such findings. The startle may be less useful in identifying nonreactive than reactive NSTs.
These results offer additional encouragement in use of the ultrasound probe-induced startle to identify fetuses with reactive NSTs and shorter testing time. While we have now reported experience with over 400 studies, these are from a single center and only two operators. Further, the number of patients with nonreactive NSTs is limited in this report. The response we describe should not currently be used as a sole predictor of fetal well-being.
